Rittenhouse Ventures

Rittenhouse Ventures is an emerging-growth venture capital firm in Philadelphia. It was previously called Emerald Stage2 Ventures and has been investing in technology businesses since 2008.

What Rittenhouse Ventures does

• Right-sized investment: provides the amount of capital a company needs at each stage, with the aim of limiting dilution for founders.
• Lead or active investor role: generally leads rounds and takes an active board seat.
• Strategic and operating support: stays involved from the first investment through to exit.
• Network access: draws on an advisory group, a director network and links with strategic and regional investors.

Who it serves

B2B software companies with recurring revenue and efficient growth. Sectors it names are IT for healthcare and pharma, finance, HR, and wider business services. It looks first at Greater Philadelphia and the Mid-Atlantic, and also at other underserved US markets. Its site features holdings such as S2N Health, StationMD and High QA, alongside a media analytics software firm.

Key facts

• Based in: Philadelphia, USA
• Founded: 2008
• Funds: Fund III closed in July 2025
• Track record: Reports more than 30 investments and 20 exits
• Leadership: Saul Richter is founder and managing partner